11/14/2024 3:25 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 4:10 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 3:55 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 4:06 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/22/2024 3:35 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 3:05 PM | Braeden Lichti (Reporting) Qualigen Therapeutics, Inc. (Issuer) Qualigen Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/09/2024 3:10 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form DEFA14A | |
|
10/09/2024 3:10 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2024 4:10 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 4:15 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2024 2:46 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 424B4 | |
09/05/2024 8:25 AM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2024 11:15 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form EFFECT | |
08/22/2024 3:41 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form S-1/A | |
08/09/2024 5:15 AM | BECHER CAMPBELL (Reporting) Qualigen Therapeutics, Inc. (Issuer) Qualigen Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 4:28 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form S-1/A | |
07/25/2024 10:57 AM | PRICE CODY (Reporting) Qualigen Therapeutics, Inc. (Issuer) Qualigen Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/18/2024 4:00 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 8:47 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form PRE 14A | |
07/15/2024 4:06 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 5:15 AM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 4:25 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 2:35 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 3:05 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form NT 10-Q | |
05/03/2024 7:59 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form S-1/A | |
05/02/2024 11:15 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form EFFECT | |
04/05/2024 8:59 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 1:35 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form NT 10-K | |
03/28/2024 3:05 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 6:00 AM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 3:30 PM | Qualigen Therapeutics, Inc. (Filer) Qualigen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |